akt inhibitors: a new type of targeted cancer drug
Published 2 years ago • 1.2K plays • Length 2:15Download video MP4
Download video MP3
Similar videos
-
1:45
target weaknesses in cancer | identifying new targets
-
8:54
akt inhibitors in research and application
-
1:37
partly by parthanatos: a new view of how akt inhibitors kill cancer cells
-
4:41
fda approved akt inhibitor for patients with advanced hr-positive breast cancer
-
57:15
212 drugs in development for rai-refractory differentiated thyroid cancer. new molecular targets
-
15:10
ending carb fear: how animal fat causes diabetes
-
1:53:19
64- predictive and prognostic tools
-
2:19
landmark moment for treatment of advanced breast cancer
-
24:12
the study of akt
-
2:20
diagnose better and earlier | the impact study
-
20:02
management of differentiated thyroid carcinoma in the era of targeted therapy
-
2:25
fingerprinting cancer metabolism
-
3:35
final results of pakt: capivasertib and paclitaxel for tnbc
-
51:40
trop2-targeting adcs as new tools in the tnbc and hr /her2- breast cancer treatment arsenal
-
0:58
professor raj chopra on exploiting cancer’s weaknesses to find new approaches to treatment
-
2:45
karen's story | combination therapies to outsmart cancer
-
59:30
improved targeting of cancers withmutations in the pi3k/pten pathway
-
2:40
viral therapy could boost limb saving cancer treatment
-
26:31
targeting advanced triple-negative breast cancer | dana-farber cancer institute
-
1:00
dr. chandarlapaty on role of the pi3k pathway in breast cancer
-
21:18
new clinical directions with abi‐009, a targeted nanoparticle mtor inhibitor